Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand

Journal of Medical Virology

Volumn 80, Issue 5, 2008, Pages 808-815

  Thongsawat, Satawat ^a   Maneekarn, Niwat ^a   Kuniholm, Mark H ^b   Pantip, Chansom ^a   Thungsuputi, Amornrat ^a   Lumlertkul, Dusit ^a   Bannachak, Derek ^a   Nelson, Kenrad E ^b,c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NONE   (United States)

Author keywords

Hemodialysis; Hepatitis C virus; Occult infection; Peripheral blood mononuclear cells; Thailand

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; EPIDEMIC; FEMALE; FOLLOW UP; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENETIC TREE; QUESTIONNAIRE; RISK FACTOR; SEROCONVERSION; STATISTICAL ANALYSIS; THAILAND; VIRUS DETECTION;

DISEASE OUTBREAKS; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; THAILAND; VIREMIA;

HEPATITIS C VIRUS;

EID: 41849139299     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21126     Document Type: Article

References (40)

1. Alebiosu CO, Ayodele OE. 2005. The global burden of chronic kidney disease and the way forward. Ethn Dis 15:418-423.
2. Arenas MD, Sanchez-Paya J, Barril G, Garcia-Valdecasas J, Gorriz JL, Soriano A, Antolin A, Lacueva J, Garcia S, Sirvent A, Espinosa M, Angoso M. 2005. A multicentric survey of the practice of hand hygiene in haemodialysis units: Factors affecting compliance. Nephrol Dial Transplant 20:1164-1171.
3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. 2006. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144:705-714.
4. Barsoum RS. 2002. Overview: End-stage renal disease in the developing world. Artif Organs 26:737-746.
5. Barsoum RS. 2006. Chronic kidney disease in the developing world. N Engl J Med 354:997-999.
6. Blackard JT, Kemmer N, Sherman KE. 2006. Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences. Hepatology 44:15-22.
7. Centers for Disease Control and Prevention. 2001. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50:1-43.
8. Cusumano A, Garcia GG, Di Gioia C, Hermida O, Lavorato C. 2006. The Latin American Dialysis and Transplantation Registry (RLDT) annual report 2004. Ethn Dis 16:S2-S3.
9. Di Libreto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, Samuel D, Ferray C. 2006. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 131: 76-84.
10. Dore GJ, Law M, MacDonald M, Kaldor JM. 2003. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 26:171-184.
11. Fabrizi F, Poordad FF, Martin P. 2002. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3-10.
12. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. 2004. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 20:1271-1277.
13. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. 1998. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retroviral 18:S11-S19.
14. Jafar TH. 2006. The growing burden of chronic kidney disease in Pakistan. N Engl J Med 354:995-997.
15. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano DD, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE. 2006. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg 74:1111-1116.
16. Maggi F, Fornai C, Morrica A, Vatteroni ML, Giorgi M, Marchi S, Ciccorossi P, Bendinelli M, Pistello M. 1999. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol 57:57-63.
17. Meguid EN, Bello AK. 2005. Chronic kidney disease: The global challenge. Lancet 365:331-340.
18. Moreira RC, Lemos MF, Longui CA, Granato C. 2005. Hepatitis C and hemodialysis: A review. Braz J Infect Dis 9:269-275.
19. Nakayama E, Akiba T, Marumo F, Sato C. 2000. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11:1896-1902.
20. Okuda K, Yokosuka O. 2004. Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up. World J Gastroenterol 10:2209-2212.
21. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. 1999. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29:217-222.
22. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. 2004. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867-5874.
23. Prentice AM. 2006. The emerging epidemic of obesity in developing countries. Int J Epidemiol 35:93-99.
24. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114.
25. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
26. Roque-Afonso AM, Ducoulombier D, Di Libreto G, Kara R, Gigou M, Dussaix E, Samuel D, Ferray C. 2005. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 79:6349-6357.
27. Rutkowski B, Ritz E. 2006. Explosion of renal replacement therapy after the implosion of the Soviet Empire. Ethn Dis 16:S2-S9.
28. Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH. 2005. Prolonged time until seroconversion among hemodialysis patients: The need for HCV PCR. Intervirology 48:213-215.
29. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567.
30. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A. 2005. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 45:334-343.
31. Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE. 2004. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 44:1433-1440.
32. The Global Burden Of Hepatitis C Working Group. 2004. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44:20-29.
33. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
34. United States Renal Data System. 2005. 2005 USRDS Annual Data Report (ADR) Atlas.
35. Wasley A, Alter MJ. 2000. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis 20:1-16.
36. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. 1995. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 60:642-647.
37. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diab Care 27:1047-1053.
38. Yach D, Stuckler D, Brownell KD. 2006. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62-66.
39. Zampieron A, Jayasekera H, Elseviers M, Lindley E, DeVos JY, Visser R, Harrington M. 2006. European study on epidemiology and management of hepatitis C virus (HCV) infection in the haemodialysis population. Part 3. Prevalence and incidence. EDTNA ERCA J 32:42-44.
40. Zuo L, Wang M. 2006. Current status of hemodialysis treatment in Beijing, China. Ethn Dis 16:S2-S4.